We are live on
!
Find out more
Nautilus Biotechnolgy
NAUT
NAUT
72 hedge funds and large institutions have $245M invested in Nautilus Biotechnolgy in 2021 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 19 increasing their positions, 9 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
223% more call options, than puts
Call options by funds: $1M | Put options by funds: $310K
200% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 8
111% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 9
29% more funds holding
Funds holding: 56 → 72 (+16)
1.56% more ownership
Funds ownership: 31.46% → 33.02% (+1.6%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
35% less capital invested
Capital invested by funds: $380M → $245M (-$135M)
Holders
72
Holders Change
+16
Holders Change %
+28.57%
% of All Funds
1.26%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
24
Increased
19
Reduced
9
Closed
8
Calls
$1M
Puts
$310K
Net Calls
+$692K
Net Calls Change
+$648K
Top Buyers
Top Sellers
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$7.33M |
| 2 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$4.18M |
| 3 |
6CM
683 Capital Management
New York
|
-$2.7M |
| 4 |
CC
Casdin Capital
New York
|
-$2.19M |
| 5 |
Jane Street
New York
|
-$1.28M |